Sort   by:  
 Page size 
ProteomicsThe proteomic response of Aspergillus fumigatus wildtype and rtaA knockout strain to Amphotericin B
Amphotericin B (AmB) and AmBisome are vital treatments for invasive fungal infections, particularly invasive aspergillosis caused by Aspergillus fumigatus spores. However, increasing resistance to AmB in clinical isolates of A. fumigatus is a growing concern. Despite this, the mechanisms of AmB resi...
ORGANISM(S): Aspergillus fumigatus CEA17 
2025-05-05 | PXD056876 | Pride
Aspergillus fumigatus Amphotericin b Antifungals Rtaa Lc-ms/ms 
UnknownThe proteomic response of Aspergillus fumigatus to amphotericin B (AmB) reveals the involvement of the RTA-like protein RtaA in AmB resistance.
Not available
S-EPMC11707875 | biostudies-literature
UnknownThe impact of endovascular repair on management and outcome of ruptured thoracic aortic aneurysms.
Not available
S-EPMC5524609 | biostudies-literature
UnknownA new Dictyostelium prestalk cell sub-type.
Not available
S-EPMC2845816 | biostudies-literature
ProteomicsAnalysis of the Aspergillus fumigatus proteomic response to amphotericin B (AmB) reveals involvement of the Rta1-like protein RtaA in resistance
The filamentous fungus Aspergillus fumigatus is an opportunistic human pathogen, which can cause mycoses and allergies in susceptible individuals. With regard to therapy, the polyene drug amphotericin B (AmB) is still frequently used to treat Aspergillus fumigatus infections due to the fact that it ...
ORGANISM(S): Neosartorya fumigata (Aspergillus fumigatus) 
2025-01-06 | PXD042190 | Pride
Lc-ms Ergosterol Antifungals Aspergillus fumigatus Amphotericin b 
Sort   by:  
 Page size